Brenntag AG (BNRA) AI Stock Analysis
Brenntag AG
(Frankfurt:BNRA)
No summary available
Brenntag AG (BNRA) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 10.32B
- Dividend Yield
- 2.97%
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- 25.2
- Beta (1Y)
- 0.88
- Revenue Growth
- -5.28%
- EPS Growth
- -13.76%
- Country
- Germany
- Employees
- 17,339
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Chemicals - Specialty
Brenntag AG Business Overview & Revenue Model
Company Description
Brenntag SE functions as a major global distributor, procuring and supplying a comprehensive range of industrial and specialty chemicals, as well as essential ingredients. Its extensive operations span across Europe, the Middle East, Africa, the Amer...
Brenntag AG Earnings Call Summary
The call presented a net-positive operational and financial picture: double-digit sales growth, margin expansion, improved EBITDA conversion and clear progress on structural cost savings and commercial initiatives. These positives were tempered by a large but described-as-temporary working capital build driven by price effects, elevated personnel costs due to bonus provisions (~EUR 40m), flat volumes in some FY-critical businesses (notably Nutrition), and continued external uncertainty (geopolitics, competitor dynamics). Management expects the working capital peak to unwind into Q3 and reiterated delivery of cost-savings targets, while taking a conservative stance on H2 gross profit assumptions.
Q2-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Management said they expect the H2 benefit from the Q2 pricing environment to unwind sequentially (moderating through Q3 and normalizing in Q4 to levels similar to prior year), while volumes remain broadly flat overall (specialties—notably Material Science—up, Nutrition flat); they flagged no significant product shortages and no backlog. Key metrics called out: Q2 working‑capital outflow of EUR 353m with inventory up ~11.8% on ~11% sales growth, working‑capital turns improved to 7.5x and the Q2 working‑capital peak should start to unwind in Q3; gross profit margin was up ~0.6 percentage points year‑on‑year and BSP EBITDA conversion rose ~3.3pp to 38.6%; personnel costs included ~EUR 40m of higher bonus provisions in Q2; cost‑saving initiatives have reached a run‑rate of EUR 41m and are expected to deliver ~EUR 150m in 2026 and EUR 200–250m in the next year.
Brenntag AG Peers Comparison
Overall Rating
ECL72Outperform
IOSP72Outperform
HWKN69Neutral
ESI62Neutral
ASH61Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 72Outperform | $85.45B | 42.51 | 20.70% | 0.93% | 9.33% | 5.71% | |
| 72Outperform | $2.44B | 14.20 | 10.41% | 2.22% | 4.73% | ― | |
| 69Neutral | $3.18B | 37.67 | 15.86% | 0.49% | 9.02% | 3.18% | |
| 62Neutral | $8.51B | 39.56 | 7.39% | 0.96% | 39.62% | -14.83% | |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 61Neutral | $3.34B | 849.33 | 0.21% | 2.18% | 2.08% | ― |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:BNRA | Brenntag Ag | 12.50 | 3.73 | 42.52% | |
| ASH | Ashland Global Holdings, Inc. | 76.44 | 27.75 | 57.00% | |
| ECL | Ecolab | 315.01 | 61.64 | 24.33% | |
| HWKN | Hawkins Inc | 155.97 | 28.77 | 22.62% | |
| IOSP | Innospec | 80.65 | 5.11 | 6.77% | |
| ESI | Element Solutions | 33.44 | 6.04 | 22.05% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.